Isabel Devesa

Isabel Devesa Giner has a strong background in pharmaceutical research and development, with a focus on chronic inflammatory conditions and pain management. Isabel has held various research positions in prestigious institutions and companies, working on projects related to neuronal mechanisms, drug development, and molecular mechanisms involved in inflammatory disorders. Isabel currently serves as the Chief Scientific Officer at Antalgenics S.L., a biotechnological company specializing in topical treatments for skin disorders and pain management. Isabel's expertise and experience make their a valuable asset in the field of pharmacology.